Eindhoven, Netherlands-based Xyall and Albuquerque, NM-based Indica Labs said Monday they are partnering to bridge the gap between histology and molecular pathology.
The partnership combines Xyall's unique automated tissue dissection solutions with Indica Labs’ artificial intelligence (AI)-enabled diagnostic digital pathology platform.
Financial and other terms of the collaboration were not disclosed.
While the field of molecular diagnostics has seen great advances in next-generation sequencing (NGS) technology alongside the rapid adoption of digital pathology, tissue dissection has remained a manual, labor-intensive process, the firms noted.
The collaboration will enable molecular laboratories to benefit from a fully digital and automated workflow for tissue macro dissection for molecular diagnostic testing, providing increased throughput and accuracy at lower operational cost, the firms added.